Editor-in-Chief
Nicola Normanno, MD
Scientific Director, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
Email: nicnorm@yahoo.com
Founding Editor-in-Chief
Graham Packham, PhD
Professor of Molecular Oncology, University of Southampton, Southampton, UK
Associate Editors
Francesco Bertoni, MD
Interests: lymphoma; novel drugs; genomics; BET; PI3K
Head, Lymphoma Genomics, Deputy Director, Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland
Giovanni Blandino, MD
Interests: tumor suppressors; non-coding RNA; Hippo pathway; PI3K inhibitors; HNSCC
Head of Oncogenomic and Epigenetic Unit, Translation Research Coordinator CTC IFO/IRE, Regina Elena Cancer Institute, Rome, Italy
Salem Chouaib, PhD
Interests: cancer immunotherapy; Killer cells; tumor microenvironment; hypoxia; cancer immunology
INSERM UMR 1186, Integrative Tumour Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine - Univ. Paris-Sud, Université Paris-Saclay, 94805, Villejuif, France; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates
Giuseppe Curigliano, MD, PhD
Interests: breast cancer; early drug development; precision oncology; biomarkers; NGS
Associate Professor of Medical Oncology, University of Milan; Head, Division of Early Drug Development, European Institute of Oncology, Milan, Italy
Gennaro Daniele, MD, PhD
Interests: drug development; clinical trials; translational research; gynecologic malignancies; biomarkers
Scientific Director, Clinical Trials Center, Agostino Gemelli University Policlinic, Rome, Italy
Massimo Di Maio, MD
Interests: clinical trials; meta-analysis; patient-reported outcomes; methodology; quality of life
Director, Division of Medical Oncology, A.O. Ordine Mauriziano; Associate Professor of Medical Oncology, Department of Oncology, University of Turin, Torino, Italy
Jianxun Ding, PhD
Interests: polymer chemistry; biomaterial; controlled drug delivery; immunotherapy; regenerative medicine
Associate Professor, Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
A. Ganesan, PhD
Interests: medicinal chemistry; chemical biology; organic synthesis; epigenetics; natural products
Professor in Chemical Biology, School of Pharmacy, University of East Anglia, Norwich, UK
Jesus Garcia-Foncillas, PhD, MD
Interests: colorectal cancer; biomarkers; gastrointestinal cancer; translational oncology
Full professsor of Oncology, School of Medicine and Director, Cancer Institute, University Hospital Fundacion Jimenez Diaz, Oncohealth Institute, Autonomous University, Madrid, Spain
Alexandros Georgakilas, PhD
Interests: DNA damage and repair; radiation biology; biological consequences of radiations; biophysics; bioinformatics; systems biology; tumor suppressors
Head of DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Athens 15780, Greece
Antonio Giordano, MD, PhD
Interests: genetics; molecular biology; pathology; oncology; environment
Present Professor, Department of Biology and Medicine; Present Director, Sbarro Health Research Organization; Present Director, Center of Biotechnology; Present Director, Professional Master Program (PSM) in Bioinnovation; Temple University, Philadelphia, PA, USA. Present “Chiara Fama” Professor, Department of Medical Biotechnology, University of Siena, Siena, Italy
Chunsheng Kang, MD, PhD
Interests: nano-medicine; signaling pathways; exosome and endocytosis; gene editing; neuro-oncology
Deputy Director of Tianjin Neurology Institute, Director of Neuro-tumor Laboratory of Tianjin Medical University General Hospital, Tianjin, China
Simon Langdon, MA, PhD
Interests: ovarian cancer; breast cancer; estrogen signaling; HER signaling; DNA repair
Reader, School of Medicine, University of Edinburgh, Edinburgh, UK
Wanliang Lu, PhD
Interests: resistant cancer; cancer stem cells; gene regulation; nanomaterials; liposomes
Professor and Vice Dean, School of Pharmaceutical Sciences, Peking University, Beijing, China
Maurie Markman, MD
Interests: ovarian cancer; gynecologic malignancies; endometrial cancer, cervix cancer; targeted therapeutics
President, Cancer Treatment Centers of America Medicine & Science; Chief Clinical Officer, CTCA Health, Philadelphia, PA, USA
Erika Martinelli, MD, PhD
Interests: colorectal cancer; translational research; resistance to targeted therapies; gastrointestinal cancer
Associate Professor in Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
Alessandro Morabito, MD
Interests: lung cancer; target based agents; angiogenesis inhibitors; immunotherapy; clinical trials
Director of Thoracic Medical Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy
Athanasios G. Papavassiliou, M.D, Ph.D
Interests: signal transduction to transcription factors in solid tumors; cancer mechanobiology
Professor of Biochemistry and Head of the Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Greece
Godefridus J. (Frits) Peters, Ph.D
Interests: cancer biomarkers; apoptosis; lung diseases; cell culture; gene expression; pharmacokinetics; pharmacodynamics; pharmacogenetics of anticancer drugs; gastrointestinal cancers; translational research
Professor of Pharmacology of cytostatics, Laboratory Medical Oncology, Amsterdam UMC, location VUMC, CCA, Netherlands;
Professor at Department of Biochemistry, Medical University of Gdansk, Poland
Arun Seth, PhD
Interests: precision oncology; breast and prostate cancer biology; molecular diagnostics; genomic profiling; next-generation sequencing; targeted cancer therapy
Scientific Director of Molecular Diagnostics, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre; Academic Director, Genomics Core Facility, Senior Scientist, Sunnybrook Research Institute; Professor, Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Canada
Gautam Sethi, PhD
Interests: signal transduction; apoptosis; transcription factors; metastasis; mouse models of cancer
Associate Professor, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore
Gareth J. Thomas, PhD
Interests: tumour microenvironment; tumor immunology; head and neck cancer; pathology; fibroblasts
Professor of Experimental Pathology, Consultant in Histopathology, University of Southampton, Southampton, UK
Editorial Board Members
Luca Agnelli, PhD
Interests: lymphoid malignancies; bioinformatics and biostatistics in cancer; -omics analyses; NGS; non-coding RNA
Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy
Matthias Baud, PhD
Interests: chemical biology; medicinal chemistry; small molecule; organic synthesis
Lecturer in Medicinal Chemistry and Chemical Biology, University of Southampton, Southampton, UK
Rossana Berardi, MD
Interests: thoracic cancer; breast cancer; neuroendocrine tumors; innovative therapies; COVID-19 and cancer
Professor in Medical Oncology and Director of the Postgraduate School of Medical Oncology at Università Politecnica Marche;
Director of Department of Medical Oncology, Director of “Genetic Cancer” Center and Breast Unit Coordinator at
Ospedali Riuniti of Ancona, Ancona, Italy
George A. Calin, MD, PhD
Interests: microRNA; non-codingRNA; cancer; therapy; biomarkers; genomics
Professor, Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, US;
Co-Director, The RNA Interference and non-codingRNA Center, The University of Texas MD Anderson Cancer Center, Houston, US;
Co-Director, MD/PhD Program, The University of Texas, Graduate School of Biomedical Sciences, Houston, US
Laura Cerchia, PhD
Interests: aptamers; cell-SELEX; cancer theranostics; cell-surface receptors; tumor‐targeted drug delivery
Research Scientist, Group Leader, Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (CNR), Naples, Italy
Fortunato Ciardiello, MD, PhD
Interests: EGFR positive lung cancer; familial colorectal cancer; lung cancer; non-small cell lung cancer
Full Professor of Medical Oncology, Director of the Division of Medical Oncology, Dean of the School of Medicine and Surgery, University of Campania Luigi Vanvitelli, Naples, Italy
Donatella Del Bufalo, PhD
Interests: melanoma; angiogenesis; bcl-2 family; tumor progression; target therapy
Senior investigator, Preclinical Models and New Therapeutic Agents Unit, Translational Research Functional
Departmental Area, Regina Elena National Cancer Institute, Rome, Italy
Eyad Elkord, PhD
Interests: tumor immunology; cancer immunotherapy; immunosuppression; T regulatory cells; immune checkpoints; cancer epigenetics
Professor, Department of Applied Biology, College of Science, University of Sharjah, Sharjah, United Arab Emirates; Honorary Professor, Biomedical Research Center, School of Science, Engineering and Environment, University of Salford, Manchester, UK
Yujiang Fang, MD, PhD
Interests: Cancer Immunotherapy; cancer Radiotherapy; urology; pathology; immunology
Associate Professor and Academic Pathologist, Department of Microbiology, Immunology and Pathology, Des Moines University, USA
Pier Francesco Ferrucci, MD
Interests: melanoma and cutaneous tumors; immuno-oncology; immunotherapy; medical oncology; targeted therapy; precision oncology
Director of Melanoma Oncology Unit, Department of Medical Oncology, European Institute of Oncology, Milan, Italy
Hamilton Gerhard, PhD
Interests: lung cancer; SCLC; NSCLC; KRAS; SOS1; BET inhibitors; preclinical drug development
Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria
Nicola Giuliani, MD, PhD
Interests: hematology; multiple myeloma; bone diseases; stem cells; pathophysiology; therapeutic targets
Full Professor of Hematology, Department of Medicine and Surgery, University of Parma, Parma, Italy
Mingzhou Guo, MD, PhD
Interests: liver cancer; hepatocellular carcinoma; PRSS3; transcript variant; intratumor heterogeneity; CpG methylation; epigenetics; biomarker
Professor, Chinese People's Liberation Army (PLA) General Hospital, Dept Gastroenterol & Hepatol, Beijing, China
Evgeny Imyanitov, MD, PhD
Interests: translational research, molecular oncology, hereditary cancer, predictive markers, lung cancer, breast cancer, ovarian cancer
Head of the Department of Tumor Biology in the N.N. Petrov Institute of Oncology;
Head of the Department of Medical Genetics in St.-Petersburg Pediatric Academy, Russian Federation
Bassam Janji, PhD
Interests: hypoxia; tumor microenvironment; anti-tumor immune response; autophagy; immunotherapy; immune surveillance; immune checkpoint blockades; epithelial-mesenchymal-transition; tumor plasticity
Head of Tumor Immunotherapy and Microenvironment (TIME) Unit, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg City, Luxembourg
Weilin Jin, MD, PhD
Interests: brain tumors; cancer stem cells; epigenetics in cancer biology; cancer immunotherapy
Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, The First Clinical Medical College of Lanzhou University, Lanzhou, China
Huangxian Ju, PhD
Interests: analytical biochemistry; nanobiosensing; bioimaging; molecular diagnosis
Director of State Key Laboratory of Analytical Chemistry for Life Science, Professor in Nanjing University, Nanjing, China
Jagat R Kanwar, PhD
Interests: precision-Nanomedicine; precision medicine; targeted-nano-theranostics; cancer targeted therapy, cancer; inflammation
All India Institute of Medical Sciences (AIIMS), Saket Nagar, Bhopal, Madhya Pradesh, India
Ning Li, MD
Interests: rare tumors; lung cancer; new anti-tumor drug research; real world research; full chain translation research of clinical trials; precision medicine of tumors; tumor big data research
Chief Physician, Professor, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences, & Peking Union Medical College, State Key Laboratory of Molecular Oncology, Beijing, China
Tao Liu, MD, PhD
Interests: cancer; long noncoding RNA; RNA methylation; drug discovery; tumorigenesis; cancer therapy
Children’s Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia
Yong-Jie Lu, MD, PhD
Interests: carcinogenesis; cancer genetics; tumor microenvironment; immune response; circulating biomarkers; male urological cancers
Professor in Molecular Oncology, Barts Cancer Institute, Barts and London School of Medicine and Dentistry, Queen Mary University of London (QMUL), London, UK
Giuseppe Lucarelli, MD, PhD
Interests: renal cancer; prostate cancer; metabolomics; cancer metabolism
Urologist and Transplant Surgeon associate Professor of Urology, University of Bari, Department of Precision and Regenerative Medicine and Ionian Area Urology, Andrology and Kidney Transplantation Unit, Bari, Italy
Joan Maurel, MD, PhD
Interests: colorectal cancer, metabolism, immune-therapy, biomarkers
Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain
Floriana Morgillo, MD, PhD
Interests: lung cancer; targeted therapy; immunotherapy; translational research; resistance mechnisms
Associate Professor in Medical Oncology, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
Yongzhan Nie, PhD
Interests: metabolism; gastric carcinoma; immunotherapy; drug resistance; targeted therapeutics
Vice Secretary, China Anti-Cancer Assocaiation; Professor and Vice director, State Key Laboratory of Cancer Biology, Xi’an, China
Seiji Okada, MD, PhD
Interests: targeting therapy; cancer immunotherapy; precision medicine; animal model; patient-derived xenograft (PDX)
Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection & Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
Zui Pan, PhD
Interests: esophageal cancer; calcium signaling; store-operated calcium entry; live cell imaging; chemotherapy
Associate Professor of College of Nursing and Health Innovation; Associate Professor of Department of Biology, The University of Texas at Arlington, Arlington, TX, USA
Pier Paolo Piccaluga, MD, Ph.D
Interests: leukemia; lymphoma; hematopathology; biomarker; next generation sequencing; microarray; molecular diagnostic, targeted therapy
Associate Professor of Pathology, MED/08, Biobank of Research & Institute of Hematology and
Medical Oncology Seràgnoli, IRCCS Azienda Ospedaliero-Universitaria di Bologna - Department of Experimental,
Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
Anna Maria Rachiglio, PharmD
Interests: biomarkers; liquid biopsy; non small cell lung cancer; colorectal cancer; next generation sequencing
Research Fellow, Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy
Lorenza Rimassa, MD
Interests: liver cancer; hepatocellular carcinoma (HCC); cholangiocarcinoma (CCA)/biliary tract cancer (BTC); biomarkers; clinical trials
Associate Professor of Medical Oncology, Department of Biomedical Sciences, Humanitas University; Deputy Director, Medical Oncology Unit, Humanitas Cancer Center, Humanitas Research Hospital, IRCCS, Milano, Italy
Ana Rovira Guerín, PhD
Interests: breast cancer; anti-HER2 therapies; immunotherapy; tumor microenvironment; biomarker of response; preclinical and translational studies
Head of the preclinical laboratory of the Molecular Cancer Therapeutics group, Cancer Research Program IMIM (Hospital del Mar Medical Research Institute), Barcelona Biomedical Research Park (PRBB), Barcelona, Spain
A. Emre Sayan, PhD
Interests: therapy resistance; metastasis; EMT; apoptosis; tumour microenvironment
Lecturer in Cancer Sciences Division, University of Southampton, Southampton, UK
Giovanni Scambia, MD
Interests: ovarian cancer; uterine cancer; vulvar cancer; molecular biology of gynecologic tumors; precision medicine in gynecological tumors
Scientific Director and Chief of the Gynecologic Oncology Unit, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, Italy
Hans-Joachim Schmoll, MD, PhD
Interests: rectal cancer; oncologic clinical trials; oncology; GI cancer
Head, Division Clinical Oncology Research University Clinic, Martin Luther University, Halle, Germany.
Director emeritus, Department of Oncology & Hematology University Clinic, Martin Luther University, Halle, Germany
Cristiana Sessa, MD
Interests: new drugs; gynaecological cancer; ovarian cancer; translational research and clinical pharmacology
Vice Head of Medical Oncology and Head of Clinical Research, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland
Xiangyang Shi, PhD
Interests: dendrimers; drug delivery; nanomedicine; theranostics; nanofibers
Professor of Biomedical Engineering, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, China
Jonathan Strefford, PhD
Interests: cancer genomics; leukemia; lymphoma; cancer epigenetics; predictive biomarkers
Professor of Molecular Oncology, Faculty of Medicine, University of Southampton, Southampton, UK
Shi-Yong Sun, PhD
Interests: lung cancer; targeted therapy; EGFR-TKI; mTOR; death receptors
Professor, Winship Cancer Institute of Emory University and Emory University School of Medicine, Atlanta, GA, USA
Hailin Tang, MD, PhD
Interests: Molecular mechanisms of malignant tumor pathogenesis and metastasis
Professor, Department of Experiment and Research, Sun Yat-Sen University Cancer Center, Guangzhou, China
Cristina Teixidó, PhD
Interests: molecular biology; lung cancer; biomarkers; targeted therapy; drug resistance
Pathology Specialist at Hospital Clinic Barcelona, Barcelona, Spain
Ratna K. Vadlamudi, PhD
Interests: women cancers; signaling pathways; therapy resistance; drug development; preclinical models
Professor, Department of Obstetrics and Gynecology & Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA
Miguel Vicente-Manzanares, PhD
Interests: cell migration; metastasis; T cell activation; T cell malignancies; cytoskeleton; adhesion; actin; myosin; integrin; signaling
Associate Professor of Research, Instituto de Biologia Molecular y Celular del Cancer (CSIC), Salamanca, Spain
Shijun Wen, PhD
Interests: anticancer drug development; medicinal chemistry; organic synthesis; epigenetics; cell metabolism
Professor in Molecular Medicine, Cancer Center, Sun Yat-sen University, Guangzhou, China
Paul Zarogoulidis, MD, PhD
Interests: drug design development and therapy; ebus, lung cancer; cancer; mesothelioma; radial ebus; robotic bronchoscopy; cios spin; o-arm; c-arm; tracheal stent; emphysema valves; immunotherapy
Pulmonary Department, “G. Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Guangrong Zheng, PhD
Interests: medicinal chemistry; organic synthesis; chemical biology; drug discovery; drug development
Associate Professor, Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, USA
